NEW YORK, NY – 24 Apr, 2016 – Creative Diagnostics, a leading supplier of life science tools that accelerates the development of biotherapeutic and pharmaceutical products, announced today that it has launched the new Immunogenicity ELISA Kit for rapid detection of high affinity anti-drug antibodies (ADA) and other targets.
The new Immunogenicity ELISA kit provides life science researchers with new levels of throughput, speed and flexibility for measuring immune response to a therapeutic drug, an integral part of drug development.
IM testing is a necessary step in the development of any biotherapeutic drug. Innovative strategies have been used to reduce the potential immunogenicity of these large molecules. However, none of these approaches ensure 100% waver from the problem of patient rejection and toxicity.
“Traditional methods for anti-drug antibody detection can be time-consuming, insensitive and labor-intensive, and can result in low throughput,” said Dr. Jessica Waldorf, chief scientific officer of R&D department of Creative Diagnostics. “In response to the fast merging of biotherapeutic drug field, Creative Diagnostics’ ready-to-use Immunogenicity ELISA Kit overcomes these limitations, providing the needed sensitivity, increased drug tolerance and flexibility to detect both high- and low-affinity ADA.”
“Each of our kit goes through fit-for-purpose validation and stability testing to ensure high accuracy, sensitivity and specificity. We are pleased to now offer our customers the ability to easily, quickly and accurately detect ADA and other targets, and enable scientists to analyze large numbers of samples in parallel, at nanoliter-scale,” pointed out by Dr. Randy S. Vaughn, director of marketing, Creative Diagnostics.
For more information about the Immunogenicity ELISA Kits, please contact Creative Diagnostics at 1-631-624-4882 or email to email@example.com
About Creative Diagnostics
Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components and critical assay reagents. It provides contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. Its goal is to provide a trusted source for all your assay development and manufacturing needs.
Distributed by Press Release Jet
Company Name: Creative Diagnostics
Contact Person: Thomas Schmitt
Email: firstname.lastname@example.org, email@example.com
Phone: Ph: 1-631-624-4882, Fx: 1-631-938-8221
Address:45-1 Ramsey Road
Country: United States